US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 11.380
  • -0.060-0.52%
Trading Mar 21 14:46 ET
461.60MMarket Cap-2.28P/E (TTM)

Keros Therapeutics Key Stats

EPS
According to the latest financial report of Keros Therapeutics, the latest earnings per share (TTM) for the company is -1.14. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about Keros Therapeutics's free cash flow? The latest report shows it as -46.30M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Keros Therapeutics shows that the company's current ratio is 21.45, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Keros Therapeutics, the quick ratio is 20.56, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of Keros Therapeutics? The latest ROE figure is -8.34%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Keros Therapeutics, the total asset return on investment (ROA) is -7.70%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Keros Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Keros Therapeutics, the net profit margin is -1.51K%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights

AI application software AI application software

AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.

Unlock Now
Discussing
地產板塊回暖!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More
focus on technology stocks
Top tech company strong as always.